Evidence map›Paper›PMID 38686211›Full record

Articlenpj antimicrobials and resistance2023

A large screen identifies beta-lactam antibiotics which can be repurposed to target the syphilis agent.

Kathryn A Hayes, Jules M Dressler, Steven J Norris, Diane G Edmondson, Brandon L Jutras

Abstract read
In one paragraph

Article in npj antimicrobials and resistance, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed.

  1. Key Considerations in Evaluating Syphilis Therapeutics.Sexually transmitted diseases · 2026
    Article
  2. Review
  3. Formal description ofInternational journal of systematic and evolutionary microbiology · 2026
    Article
  4. Article
  5. Article
  6. Frontiers in immunology · 2026
    Review
  7. Article
  8. Article
  9. In vitro isolation of contemporary Treponema pallidum strains directly from clinical samples of syphilis patients.Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases · 2025
    Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Kathryn A HayesTranslational Biology, Medicine, and Health, Virginia Tech, Blacksburg, VA 24061 USA.ORCID 0000-0002-6057-6509
Jules M DresslerFralin Life Sciences Institute, Virginia Tech, Blacksburg, VA 24061 USA.ORCID 0000-0001-5460-8968
Steven J NorrisDepartment of Pathology and Laboratory Medicine, University of Texas Health Science Center at Houston, Houston, TX USA.
Diane G EdmondsonDepartment of Pathology and Laboratory Medicine, University of Texas Health Science Center at Houston, Houston, TX USA.
Brandon L JutrasTranslational Biology, Medicine, and Health, Virginia Tech, Blacksburg, VA 24061 USA.ORCID 0000-0002-7989-1031

Funding

Factors Affecting longterm in vitro culture of Treponema pallidumR01AI141958 · NIAID · UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON · PI Diane G Edmondson, STEVEN J. NORRIS · 2018 to 2026
$3.9M
The natural release of Treponema pallidum peptidoglycan as a pathogenic determinant of syphilisF31AI181555 · NIAID · NORTHWESTERN UNIVERSITY AT CHICAGO · PI HAYES, KATHRYN ADAIR · 2024 to 2025
$99k
NIAID NIH HHS F31 AI181555NIAID NIH HHS R01 AI141958
6 · The paper itself

Abstract

Syphilis, caused by the spirochete

Indexed as

BacteriologyGlycobiology

Identifiers

PMID38686211
PMCPMC11057208

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.